| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NeuBase Therapeutics, Inc. | Chief Medical Officer | Employee stock option (right to buy) | 44,592 | 24 Jan 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NBSE | NeuBase Therapeutics, Inc. | 24 Jan 2022 | 1 | $0 | 4 | Chief Medical Officer | 25 Jan 2022, 13:00 |
| NBSE | NeuBase Therapeutics, Inc. | 24 May 2021 | 1 | $0 | 4 | Chief Medical Officer | 25 May 2021, 16:13 |
| NBSE | NeuBase Therapeutics, Inc. | 24 May 2021 | 0 | $0 | 3 | Chief Medical Officer | 25 May 2021, 16:10 |